Skip to content

FOR LABORATORY RESEARCH USE ONLY — not for human or veterinary use, diagnosis, treatment, or cosmetic application. Buyers must be 21+ and legally permitted to purchase research chemicals in their jurisdiction.Intended-use statement →

Survodutide Wholesale

Dual glucagon / GLP-1 receptor agonist studied in metabolic and hepatic research models

Product Identity

CAS Number2805997-46-8
Molecular FormulaC₁₉₂H₂₈₉N₄₇O₆₁
Molecular Weight~4,232 Da
AppearanceWhite to off-white lyophilized powder
Purity≥99% by HPLC
SolubilitySoluble in sterile water or PBS
Storage2–8°C, desiccated, protect from light
IdentificationESI-MS identity confirmation on each batch

Available Configurations

ConfigurationContentBest For
Standard Kit10 mg × 10 vialsProtocol validation; evaluation orders
CustomCustom mg × custom vialsOEM; private-label; protocol-specific

Research Background

Survodutide is a dual glucagon receptor (GCGR) and GLP-1 receptor agonist. Published research on this analogue class focuses on combined incretin and glucagon signalling, including hepatic lipid-handling and fibrosis-related endpoints in animal models, which makes it a reference compound for dual-agonist metabolic research.

Proposed Mechanisms

GCGR agonismGlucagon-receptor activation studied for energy-expenditure and hepatic-lipid endpoints
GLP-1R agonismIncretin signalling contributing to the dual-agonist profile
Hepatic lipid handlingExplored in liver-focused metabolic research models

Research Focus Areas

Dual-Agonist Research

Combined GCGR/GLP-1R pharmacology

Hepatic Metabolism

Liver lipid and fibrosis-model research

Metabolic Portfolio Design

Comparison against single-target incretins

Quality Specifications

ParameterMethodCriterion
PurityHPLC at 214 nm, C18 column≥99.0% peak area
IdentityESI-MSDa
AppearanceVisual inspectionWhite to off-white lyophilized powder
Purity assayAmino acid analysis≥80% net peptide
Residual moistureKarl Fischer≤3%
SolubilityReconstitution testSoluble in sterile water or PBS

Tiered Wholesale Pricing

Kit sizeCodeList price
10 mg × 10 vialsSUR10US$291

US$291–291 per kit (10 vials), from our published wholesale price list; tiered volume discounts apply (see the tier table) — source:wholesale price list (PDF, updated 2026-08-08).

VolumeDiscountFor
1 kitList priceEvaluation; competitive analysis
5+ kits10% offInitial portfolio expansion
20+ kits20% offMid-size distributors
50+ kits30% offRegional distributors

FAQ

What is Survodutide?

Survodutide (CAS 2805997-46-8) is a dual glucagon and GLP-1 receptor agonist peptide supplied for laboratory research use only.

Which research endpoints is it associated with?

Published work on this analogue class reports energy-expenditure, hepatic lipid and fibrosis-related endpoints in animal models. We do not make efficacy or clinical claims for research peptides.

What does a kit contain?

10 mg × 10 vials per kit, lyophilized, with a batch-specific COA (HPLC purity and MS identity).

How should it be stored?

Store lyophilized powder desiccated at 2–8°C protected from light; after reconstitution aliquot and freeze, and avoid repeated freeze–thaw cycles.

All products are manufactured for laboratory research purposes only. Survodutide is labeled FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary use, diagnosis, treatment, prophylaxis or any clinical, cosmetic, dietary or household application. Not a dietary supplement, pharmaceutical ingredient, cosmetic ingredient or approved drug substance. Buyers are responsible for verifying the legal status of importation and possession in their destination country.

Ready to Source Survodutide?

Bulk pricing, tiered discounts up to 30%, COA with every order.

← Back to Metabolic Research